Zimmer Biomet Holdings Asia Pacific — Cost of Goods Sold decreased by 26.1% to $88.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from $83.30M to $88.00M. Over 3 years (FY 2022 to FY 2025), Asia Pacific — Cost of Goods Sold shows an upward trend with a 4.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Lower costs relative to revenue indicate improved manufacturing efficiency or favorable product mix.
The direct costs associated with manufacturing, sourcing, and delivering orthopedic products and services within the Asi...
Standard cost accounting metric used across the manufacturing and medical device sectors.
zbh_segment_asia_pacific_cost_of_goods_and_services_sold| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $94.80M | $94.80M | $94.80M | $94.80M | $90.63M | $90.63M | $90.63M | $90.63M | $75.10M | $99.70M | $98.00M | $102.70M | $83.30M | $118.60M | $116.40M | $119.00M | $88.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -4.4% | +0.0% | +0.0% | +0.0% | -17.1% | +32.8% | -1.7% | +4.8% | -18.9% | +42.4% | -1.9% | +2.2% | -26.1% |
| YoY Change | — | — | — | — | -4.4% | -4.4% | -4.4% | -4.4% | -17.1% | +10.0% | +8.1% | +13.3% | +10.9% | +19.0% | +18.8% | +15.9% | +5.6% |